545 related articles for article (PubMed ID: 19601710)
1. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
Meredith PA
Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
[TBL] [Abstract][Full Text] [Related]
2. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
3. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
Bialer M; Midha KK
Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
[TBL] [Abstract][Full Text] [Related]
5. Amlodipine bioequivalence achieved with a very sensitive liquid chromatography tandem mass spectrometric bioassay.
Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Uhr MR; La Commare P
Arzneimittelforschung; 2000 Aug; 50(8):688-94. PubMed ID: 10994151
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the switchability of generic products.
Karalis V; Bialer M; Macheras P
Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
[TBL] [Abstract][Full Text] [Related]
8. Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers.
Mignini F; Tomassoni D; Traini E; Amenta F
Clin Exp Hypertens; 2007 Nov; 29(8):539-52. PubMed ID: 18058479
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence and narrow therapeutic index drugs.
Benet LZ; Goyan JE
Pharmacotherapy; 1995; 15(4):433-40. PubMed ID: 7479195
[TBL] [Abstract][Full Text] [Related]
10. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
Dupont AG; Heller F
Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of generic agents in psychopharmacologic treatment.
Kumet R; Gelenberg AJ
Essent Psychopharmacol; 2005; 6(2):104-11. PubMed ID: 15765794
[TBL] [Abstract][Full Text] [Related]
12. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
Carrillo Norte JA; Postigo Mota S
Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
[TBL] [Abstract][Full Text] [Related]
13. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
Lee SY; Kim JR; Jung JA; Huh W; Bahng MY; Ko JW
Drug Des Devel Ther; 2015; 9():2811-7. PubMed ID: 26082611
[TBL] [Abstract][Full Text] [Related]
15. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis for bioequivalence studies: interchangeability of generic drugs and similar containing Hydrochlorothiazide is possible but not with Enalapril Maleate.
Lopes RA; Neves Fde A
J Bras Nefrol; 2010; 32(2):173-81. PubMed ID: 21103677
[TBL] [Abstract][Full Text] [Related]
17. Variability and impact on design of bioequivalence studies.
Van Peer A
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.
Marzo A; Balant LP
Arzneimittelforschung; 1995 Feb; 45(2):109-15. PubMed ID: 7710428
[TBL] [Abstract][Full Text] [Related]
19. [Generic drugs: quality, efficacy, safety and interchangeability].
Tschabitscher D; Platzer P; Baumgärtel C; Müllner M
Wien Klin Wochenschr; 2008; 120(3-4):63-9. PubMed ID: 18322766
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic equivalence of complex drugs.
Schellekens H; Klinger E; Mühlebach S; Brin JF; Storm G; Crommelin DJ
Regul Toxicol Pharmacol; 2011 Feb; 59(1):176-83. PubMed ID: 20951177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
